Bangladesh Signs MOU To Manufacture China’s Sinopharm COVID-19 Inactivated Vaccine

Bangladesh Signs MOU To Manufacture China’s Sinopharm COVID-19 Inactivated Vaccine

DHAKA, Aug 18 (NNN-BSS) – Bangladesh is all set to start locally manufacturing China’s Sinopharm COVID-19 inactivated vaccine, as an agreement on co-production of the Chinese jab was signed via video with relevant authorities.

The memorandum of understanding (MoU) was signed between China’s Sinopharm Group, Bangladesh’s Ministry of Health and Family Welfare and Incepta Vaccine Ltd., a leading local vaccine manufacturing company, on Monday afternoon.

Chinese Ambassador to Bangladesh, Li Jiming said, the successful signing of the MoU will be a successful model for cooperation between China and South Asian countries. He emphasised that, vaccine cooperation requires full mobilisation and joint efforts from the government and enterprises.

Bangladeshi Health and Family Welfare Minister, Zahid Maleque, said, the signing of the agreement is a new milestone in China-Bangladesh’s relationship.

The minister expressed hope that the local production of the Chinese vaccine will be started as soon as possible.

For his part, Bangladeshi Foreign Minister, AK Abdul Momen said, it is a historic day for Bangladesh and China-Bangladesh friendship.

Liu Jingzhen, chairman of Sinopharm Group, said, after the agreement is implemented, the Bangladeshi company will be able to distribute at least five million doses of COVID-19 inactivated vaccine every month, for local pandemic prevention and control.– NNN-BSS

administrator

Related Articles